Physician profile
Charles V Beall
NPI 1457321853
$8,937.77
in general payments reported to CMS, 2019-2025
12 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,123 · 2020: $1,773 · 2021: $107 · 2022: $34.26 · 2023: $4,396 · 2024: $337 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,109 · Food and Beverage: $561 · Travel and Lodging: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,108.66 |
| Food and Beverage | $561.29 |
| Travel and Lodging | $231.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,288.10 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $221.61 | 2021-2025 | Echelon Flex |
| Stryker Corporation | $175.45 | 2019-2025 | Molli |
| Ethicon US, LLC | $65.59 | 2020-2023 | Megadyne |
| Hologic Sales and Service, LLC | $37.36 | 2023 | Localizer |
| Shire North American Group INC | $36.96 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.80 | 2019 | |
| Davol INC. | $23.93 | 2019 | |
| Abbvie INC. | $18.82 | 2019 | |
| Leica Microsystems INC. | $15.76 | 2022 | |
| Ucb, INC. | $13.90 | 2019 | |
| Steris Corporation | $13.49 | 2025 | Amsco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Beall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.